ORAMED PHARMACEUTICALS INC. 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Mar 21, 2017
Insider Transaction Report
Form 4
Law Ronald Edward
Chief Strategy Officer
Transactions
- Award
Stock Option (right to buy)
2017-03-20+37,152→ 37,152 totalExercise: $6.00Exp: 2027-03-20→ Common Stock (37,152 underlying)
Footnotes (1)
- [F1]The Stock Option shall vest in 24 consecutive equal monthly installments commencing March 31, 2017.